clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Vaccines
What Can We Expect From The Second Wave of Coronavirus Vaccines?
Oligonucleotides
Targeted Multiple Myeloma Treatment Silences IRF4 Gene
Patient Care
New Genetic Disorder Affecting Brain, Heart, and Facial Features Discovered
Precision Medicine
Biomarker-Informed Treatments for Gastric Cancer Patients Improve Outcomes
Precision Medicine
Thermo Fisher to Buy POC Molecular Dx Provider Mesa Biotech
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Vaccines
What Can We Expect From The Second Wave of Coronavirus Vaccines?
Oligonucleotides
Targeted Multiple Myeloma Treatment Silences IRF4 Gene
Patient Care
New Genetic Disorder Affecting Brain, Heart, and Facial Features Discovered
Precision Medicine
Biomarker-Informed Treatments for Gastric Cancer Patients Improve Outcomes
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Marketplace
Multimedia
All
Webinars
eBooks
Upcoming Webinars
Genomic Applications in the Fight against SARS-CoV-2
eBooks
Cell and Gene Therapy Clinical Trials
On Demand Webinars
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Upcoming Webinars
Comprehensive Genomic and Immune Profiling to Support Drug Development
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Therapeutics
Vaccines
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Vaccines
What Can We Expect From The Second Wave of Coronavirus Vaccines?
January 22, 2021
Vaccines
Melanoma Vaccine from NeoVox Shows Anti-Tumor Response Four Years Later
January 21, 2021
Vaccines
Novavax’s COVID-19 Vaccine Candidate Moves into Phase III Trial
January 4, 2021
Vaccines
Moderna’s COVID-19 Vaccine Gets Emergency Use Authorization From the FDA
December 21, 2020
Vaccines
Older Adults’ Responses to Vaccine Improved by Autophagy Aid Spermidine
December 16, 2020
Vaccines
FDA Grants EUA for Pfizer/BioNTech COVID-19 Vaccine
December 14, 2020
Vaccines
Pfizer/BioNTech COVID-19 Vaccine Poised for FDA Emergency Use Authorization
December 11, 2020
Vaccines
Researchers Seek to Detail Nuances of Immunity to SARS-CoV-2
December 7, 2020
Vaccines
Pfizer, BioNTech’s COVID-19 Vaccine Gains Temporary U.K. Authorization
December 2, 2020
Vaccines
EUA for COVID-19 Vaccine Sought by Moderna
November 30, 2020
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Researchers at The University of Texas MD Anderson Cancer Center have found that a rare resistance mutation first thought to appear in melanoma (pictured) following treatment with a targeted therapy has instead turned out to be hiding in the tumor all along. [Definiens]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1519-324x160.jpeg "Melanoma Vaccine from NeoVox Shows Anti-Tumor Response Four Years Later")
